A novel predictor of clinical response to methotrexate in patients with rheumatoid arthritis: A pilot study of in vitro T cell cytokine suppression

Journal of Rheumatology

Volumn 35, Issue 6, 2008, Pages 975-978

  Haroon, Nigil ^a   Srivastava, Rajni ^a   Misra, Ramnath ^a   Aggarwal, Amita ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Cytokines; Disease modifying antirheumatic drugs; Drug response; Early rheumatoid arthritis; Prediction; Prognosis

Indexed keywords

ALLOANTIBODY; CD28 ANTIBODY; CD3 ANTIBODY; FOLIC ACID; GAMMA INTERFERON; INTERLEUKIN 10; METHOTREXATE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD CULTURE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE ACTIVITY; DRUG DOSE INCREASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOMODULATION; IN VITRO STUDY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SUPERNATANT; T LYMPHOCYTE ACTIVATION; TREATMENT OUTCOME;

ADULT; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CELLS, CULTURED; COHORT STUDIES; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; MALE; METHOTREXATE; MIDDLE AGED; PILOT PROJECTS; ROC CURVE; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 44949174174     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Sokka T, Krishnan E, Häkkinen A, Hannonen P. Functional disability in rheumatoid arthritis patients compared with a community population in Finland. Arthritis Rheum 2003;48:59-63.
2. Hakoda M, Oiwa H, Kasagi F, et al. Mortality of rheumatoid arthritis in Japan: a longitudinal cohort study. Ann Rheum Dis 2005;64:1451-5.
3. Finckh A, Liang MH, Van Herckenrode CM, de Pablo P. Long term impact of early treatment on radiographic progression in early rheumatoid arthritis: a meta-analysis. Arthritis Rheum 2006;55:864-72.
4. Cornstein BN. Low dose methotrexate: a mainstay in therapy of rheumatoid arthritis. Pharmacol Rev 2005;57:163-72.
5. van der Heijde D, Klareskog L, Rodriguez-Valverde V, et al. Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial. Arthritis Rheum 2006;54:1063-74.
6. Anderson JJ, Wells G, Verhoeven AC, Felson DT. Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration. Arthritis Rheum 2000;43:22-9.
7. Matteson EL, Weyand CM, Fulbright JW, Christianson TJH, McClelland RL, Goronzy RL. How aggressive should initial therapy for rheumatoid arthritis be? Factors associated with response to 'non-aggressive' DMARD treatment and perspective from a 2-yr open label trial. Rheumatology Oxford 2004;43:619-25.
8. Kremer JM. Towards a better understanding of methotrexate. Arthritis Rheum 2004;50:1370-82.
9. Dervieux T, Greenstein N, Kremer J. Pharmacogenomic and metabolic biomarkers in the folate pathway and their association with methotrexate effects during dosage escalation in rheumatoid arthritis. Arthritis Rheum 2006;54:3095-103.
10. Gerards AH, de Lathouder S, de Groot ER, Dijkmans BAC, Aarden LA. Inhibition of cytokine production by methotrexate. Studies in healthy volunteers and patients with rheumatoid arthritis. Rheumatology Oxford 2003;42:1189-96.
11. Fransen J, van Riel PL. The Disease Activity Score and EULAR response criteria. Clin Exp Rheumatol 2005;23:S93-9.
12. Felson DT, Anderson JJ, Boers M, et al. American College of Rheumatology: preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995;38:727-35.
13. Neurath MF, Hildner K, Becker C, et al. Methotrexate specifically modulates cytokine production by T cells and macrophages in murine collagen induced arthritis (CIA): a mechanism for methotrexate mediated immunosuppression. Clin Exp Immunol 1999;115:42-55.
14. Fairbanks LD, Ruckemann K, Qiu Y, et al. Methotrexate inhibits the first committed step of purine biosynthesis in mitogen-stimulated human T-lymphocytes: a metabolic basis for efficacy in rheumatoid arthritis? Biochem J 1999;342:143-52.
15. Strand V, Cohen S, Schiff M, et al. Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Arch Intern Med 1999;159:2542-50.